Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-014256
Filing Date
2023-01-24
Accepted
2023-01-24 16:32:42
Documents
9
Effectiveness Date
2023-01-24

Document Format Files

Seq Description Document Type Size
1 S-8 d421215ds8.htm S-8 63296
2 EX-4.4 d421215dex44.htm EX-4.4 43414
3 EX-4.5 d421215dex45.htm EX-4.5 32999
4 EX-5.1 d421215dex51.htm EX-5.1 62564
5 EX-23.2 d421215dex232.htm EX-23.2 1815
6 EX-23.3 d421215dex233.htm EX-23.3 1608
7 EX-FILING FEES d421215dexfilingfees.htm EX-FILING FEES 15866
8 GRAPHIC g421215g44t79.jpg GRAPHIC 3096
9 GRAPHIC g421215g72s81.jpg GRAPHIC 2047
  Complete submission text file 0001193125-23-014256.txt   229956
Mailing Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF
Business Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF 4403330237300
Mereo Biopharma Group plc (Filer) CIK: 0001719714 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-269388 | Film No.: 23548530
SIC: 2834 Pharmaceutical Preparations